NEU1 and neurodegenerative disease: The interplay between NEU1 and various signaling pathways, including those involved in inflammation and cellular stress responses, highlights the potential for targeted pharmacological interventions to recalibrate NEU1 activity in the context of neurodegenerative diseases [57].